Lab Testing from Genics Laboratories – Convenient At-Home Tests Available
Shop Tests

Carcinoembryonic Antigen

Test Overview

The Carcinoembryonic Antigen (CEA) test measures the level of CEA, a protein that is produced by certain types of cancer cells and, to a lesser extent, in healthy cells. While CEA levels can be elevated in a variety of conditions, this test is most commonly used to help monitor cancer treatment, detect cancer recurrence, or assess the effectiveness of treatment for certain cancers, particularly colorectal cancer. High levels of CEA may indicate the presence of cancer or other non-cancerous conditions.

Test Uses

  • Monitor cancer treatment: Used to track the effectiveness of treatment for cancers like colorectal cancer, breast cancer, lung cancer, and others.
  • Detect cancer recurrence: Elevated CEA levels can indicate that a cancer has returned after treatment.
  • Aid in cancer diagnosis: CEA levels may be elevated in individuals with certain types of cancer.
  • Assess for non-cancerous conditions: Elevated levels can also be seen in conditions unrelated to cancer, including liver disease, inflammatory bowel disease, and pancreatitis.

CEA Test Results & Ranges

Test Component:Normal Range:Abnormal Levels Indicate:
Carcinoembryonic Antigen (CEA)< 5 ng/mL (non-smokers)
< 10 ng/mL (smokers)		High: Colorectal cancer, lung cancer, breast cancer, pancreatic cancer, liver disease, inflammatory bowel disease, pancreatitis, or cirrhosis

Interpreting Abnormal CEA Levels:

  • High CEA Levels:

    • Colorectal Cancer: CEA is most commonly associated with colorectal cancer, where elevated levels are often seen, especially in advanced stages.
    • Other Cancers: Elevated CEA levels can also be seen in other types of cancer, such as lung cancer, breast cancer, pancreatic cancer, and gastric cancer.
    • Non-Cancerous Conditions: Elevated CEA may be seen in benign conditions like liver disease, pancreatitis, chronic obstructive pulmonary disease (COPD), inflammatory bowel disease, and cirrhosis.
    • Smoking: Smokers tend to have higher baseline levels of CEA, though it is not necessarily linked to cancer.

  • Normal CEA Levels:

    • Non-smokers: Generally, CEA levels below 5 ng/mL are considered normal in non-smokers.
    • Smokers: CEA levels below 10 ng/mL are considered normal in smokers.
    • Normal Levels in Cancer Patients: Normal CEA levels do not rule out the presence of cancer; some patients with early-stage cancer may have low or normal CEA levels.

Expected Turnaround Time

  • Results Available: Typically within 1–2 days.

Specimen Requirements

  • Sample Type: Blood (serum).
  • Container: Serum separator tube (SST, gold-top tube) or plain red-top tube.

Collection Instructions

  • Fasting: This test generally does not require fasting.
  • Medications: Inform your healthcare provider about any medications you are taking, as certain treatments may affect CEA levels.

Test Details

Clinical Use: The CEA test is primarily used for monitoring cancer treatment and detecting recurrence in patients who have been diagnosed with cancers such as colorectal cancer. It is also used to help assess the prognosis of some cancers and guide treatment decisions. While it is helpful for monitoring cancer, CEA is not recommended as a screening test for cancer in individuals who do not have symptoms or a known diagnosis, as elevated levels can occur in non-cancerous conditions. The CEA test may also be used in conjunction with other tumor markers and diagnostic tools to make a more comprehensive assessment.

Limitations: False positives: Elevated CEA levels can be caused by conditions other than cancer, such as liver disease, pancreatitis, and inflammatory bowel disease. False negatives: Not all cancers will result in elevated CEA levels, and some individuals with advanced cancer may have low or normal CEA levels. Non-specific: CEA is a non-specific marker, meaning that while it can indicate the presence of cancer, it cannot pinpoint the type or location of the cancer without further testing. Smoking Impact: Smokers tend to have higher baseline levels, which can complicate interpretation, especially in non-cancer patients.

The Carcinoembryonic Antigen (CEA) test is a critical tool for monitoring certain cancers, especially colorectal cancer, and for detecting recurrence after treatment. While it is valuable in clinical settings, it should always be interpreted alongside other diagnostic tests and clinical findings to ensure accurate diagnosis and treatment decisions.

0